166 related articles for article (PubMed ID: 20061936)
1. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
Van der Kwast TH; Evans A; Lockwood G; Tkachuk D; Bostwick DG; Epstein JI; Humphrey PA; Montironi R; Van Leenders GJ; Pihl CG; Neetens I; Kujala PM; Laurila M; Mazerolles C; Bubendorf L; Finelli A; Watson K; Srigley J
Am J Surg Pathol; 2010 Feb; 34(2):169-77. PubMed ID: 20061936
[TBL] [Abstract][Full Text] [Related]
2. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").
Montironi R; Scattoni V; Mazzucchelli R; Lopez-Beltran A; Bostwick DG; Montorsi F
Eur Urol; 2006 Oct; 50(4):666-74. PubMed ID: 16930809
[TBL] [Abstract][Full Text] [Related]
3. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
4. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic concordance in biopsies of deceptive prostatic carcinoma.
Arista-Nasr J; Cortés E; Keirns C; Hatchett A; Loría A
Rev Invest Clin; 1996; 48(4):289-96. PubMed ID: 8916448
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic issues in second opinion consultations in prostate pathology.
Jara-Lazaro AR; Thike AA; Tan PH
Pathology; 2010 Jan; 42(1):6-14. PubMed ID: 20025474
[TBL] [Abstract][Full Text] [Related]
7. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens.
Jiang Z; Iczkowski KA; Woda BA; Tretiakova M; Yang XJ
Am J Clin Pathol; 2004 Jan; 121(1):99-107. PubMed ID: 14750247
[TBL] [Abstract][Full Text] [Related]
8. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
Helpap B; Köllermann J; Oehler U
J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical pitfalls in prostate pathology.
Brimo F; Epstein JI
Hum Pathol; 2012 Mar; 43(3):313-24. PubMed ID: 22325142
[TBL] [Abstract][Full Text] [Related]
10. Routine dual-color immunostaining with a 3-antibody cocktail improves the detection of small cancers in prostate needle biopsies.
Tolonen TT; Kujala PM; Laurila M; Tirkkonen M; Ilvesaro J; Tuominen VJ; Tammela TL; Isola J
Hum Pathol; 2011 Nov; 42(11):1635-42. PubMed ID: 21497369
[TBL] [Abstract][Full Text] [Related]
11. [Prostatic adenocarcinoma--still a diagnostic problem].
Helpap B
Verh Dtsch Ges Pathol; 2004; 88():152-7. PubMed ID: 16892546
[TBL] [Abstract][Full Text] [Related]
12. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
Roobol MJ; van der Cruijsen IW; Schröder FH
Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
[TBL] [Abstract][Full Text] [Related]
13. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
[TBL] [Abstract][Full Text] [Related]
14. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry.
Helin HO; Lundin ME; Laakso M; Lundin J; Helin HJ; Isola J
J Urol; 2006 Feb; 175(2):495-9. PubMed ID: 16406979
[TBL] [Abstract][Full Text] [Related]
15. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up.
Wolters T; van der Kwast TH; Vissers CJ; Bangma CH; Roobol M; Schröder FH; van Leenders GJ
Am J Surg Pathol; 2010 Jan; 34(1):35-43. PubMed ID: 19935058
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.
Kunju LP; Rubin MA; Chinnaiyan AM; Shah RB
Am J Clin Pathol; 2003 Nov; 120(5):737-45. PubMed ID: 14608901
[TBL] [Abstract][Full Text] [Related]
17. Characterization of minute adenocarcinomas of prostate at radical prostatectomy.
Truskinovsky AM; Sanderson H; Epstein JI
Urology; 2004 Oct; 64(4):733-7. PubMed ID: 15491711
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
Roobol MJ; Kranse R; de Koning HJ; Schröder FH
Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
van der Kwast TH; Hoedemaeker RF; Schröder FH
Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
[TBL] [Abstract][Full Text] [Related]
20. Needle biopsies of the prostate: what constitutes adequate histologic sampling?
Lane RB; Lane CG; Mangold KA; Johnson MH; Allsbrook WC
Arch Pathol Lab Med; 1998 Sep; 122(9):833-5. PubMed ID: 9740145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
